Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases

Maria Elena Laino, Serena Monti, David S Klimstra, Laura H Tang, Lorenzo Mannelli

Research output: Contribution to journalArticle

Abstract

A 7-year-old patient with a stage 4 neuroblastoma underwent chemotherapy, surgery, myeloablative therapy, external beam radiotherapy, and Isoretinoin treatment. A posttreatment magnetic resonance examination performed administering gadoteric acid as contrast agent showed 2 new hypervascular hepatic lesions, suspicious for metastases. A second magnetic resonance imaging performed using a liver-specific contrast medium (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) demonstrated that these lesions were consistent with treatment-related focal nodular hyperplasia.

Original languageEnglish
JournalJournal of Pediatric Hematology/Oncology
DOIs
Publication statusE-pub ahead of print - Nov 28 2018

Fingerprint

Focal Nodular Hyperplasia
Neoplasm Metastasis
Contrast Media
Liver
Pentetic Acid
Gadolinium
Neuroblastoma
Magnetic Resonance Spectroscopy
Radiotherapy
Therapeutics
Magnetic Resonance Imaging
Drug Therapy
Acids

Cite this

Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases. / Laino, Maria Elena; Monti, Serena; Klimstra, David S; Tang, Laura H; Mannelli, Lorenzo.

In: Journal of Pediatric Hematology/Oncology, 28.11.2018.

Research output: Contribution to journalArticle

Laino, Maria Elena ; Monti, Serena ; Klimstra, David S ; Tang, Laura H ; Mannelli, Lorenzo. / Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases. In: Journal of Pediatric Hematology/Oncology. 2018.
@article{5e0ac9e540e44972a44dd82b9115177d,
title = "Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases",
abstract = "A 7-year-old patient with a stage 4 neuroblastoma underwent chemotherapy, surgery, myeloablative therapy, external beam radiotherapy, and Isoretinoin treatment. A posttreatment magnetic resonance examination performed administering gadoteric acid as contrast agent showed 2 new hypervascular hepatic lesions, suspicious for metastases. A second magnetic resonance imaging performed using a liver-specific contrast medium (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) demonstrated that these lesions were consistent with treatment-related focal nodular hyperplasia.",
author = "Laino, {Maria Elena} and Serena Monti and Klimstra, {David S} and Tang, {Laura H} and Lorenzo Mannelli",
year = "2018",
month = "11",
day = "28",
doi = "10.1097/MPH.0000000000001362",
language = "English",
journal = "Journal of Pediatric Hematology/Oncology",
issn = "1077-4114",
publisher = "Lippincott Williams and Wilkins",

}

TY - JOUR

T1 - Treatment-related Focal Nodular Hyperplasia Mimicking Liver Metastases

AU - Laino, Maria Elena

AU - Monti, Serena

AU - Klimstra, David S

AU - Tang, Laura H

AU - Mannelli, Lorenzo

PY - 2018/11/28

Y1 - 2018/11/28

N2 - A 7-year-old patient with a stage 4 neuroblastoma underwent chemotherapy, surgery, myeloablative therapy, external beam radiotherapy, and Isoretinoin treatment. A posttreatment magnetic resonance examination performed administering gadoteric acid as contrast agent showed 2 new hypervascular hepatic lesions, suspicious for metastases. A second magnetic resonance imaging performed using a liver-specific contrast medium (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) demonstrated that these lesions were consistent with treatment-related focal nodular hyperplasia.

AB - A 7-year-old patient with a stage 4 neuroblastoma underwent chemotherapy, surgery, myeloablative therapy, external beam radiotherapy, and Isoretinoin treatment. A posttreatment magnetic resonance examination performed administering gadoteric acid as contrast agent showed 2 new hypervascular hepatic lesions, suspicious for metastases. A second magnetic resonance imaging performed using a liver-specific contrast medium (gadolinium ethoxybenzyl diethylenetriamine pentaacetic acid) demonstrated that these lesions were consistent with treatment-related focal nodular hyperplasia.

U2 - 10.1097/MPH.0000000000001362

DO - 10.1097/MPH.0000000000001362

M3 - Article

C2 - 30499907

JO - Journal of Pediatric Hematology/Oncology

JF - Journal of Pediatric Hematology/Oncology

SN - 1077-4114

ER -